384 related articles for article (PubMed ID: 32339299)
41. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
Frederiksen LSF; Zhang Y; Foged C; Thakur A
Front Immunol; 2020; 11():1817. PubMed ID: 32793245
[TBL] [Abstract][Full Text] [Related]
42. "Trained immunity" from Mycobacterium spp. exposure or BCG vaccination and COVID-19 outcomes.
Singh S; Maurya RP; Singh RK
PLoS Pathog; 2020 Oct; 16(10):e1008969. PubMed ID: 33119725
[TBL] [Abstract][Full Text] [Related]
43. Expansion of atypical memory B cells is a prominent feature of COVID-19.
Oliviero B; Varchetta S; Mele D; Mantovani S; Cerino A; Perotti CG; Ludovisi S; Mondelli MU
Cell Mol Immunol; 2020 Oct; 17(10):1101-1103. PubMed ID: 32879471
[No Abstract] [Full Text] [Related]
44. Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2.
Glisic S; Perovic VR; Sencanski M; Paessler S; Veljkovic V
J Proteome Res; 2020 Nov; 19(11):4649-4654. PubMed ID: 32794723
[TBL] [Abstract][Full Text] [Related]
45. Mechanistic inferences from clinical reports of SARS-CoV-2.
Jenkins MM; McCaw TR; Goepfert PA
Infect Dis (Lond); 2020 Aug; 52(8):527-537. PubMed ID: 32459123
[TBL] [Abstract][Full Text] [Related]
46. Is BCG vaccination causally related to reduced COVID-19 mortality?
Miyasaka M
EMBO Mol Med; 2020 Jun; 12(6):e12661. PubMed ID: 32379923
[TBL] [Abstract][Full Text] [Related]
47. Good news or bad news? The coronavirus pandemic has sickened and killed only a relatively few people but has affected us all.
Calisher CH
Croat Med J; 2020 Jul; 61(3):296-299. PubMed ID: 32643349
[No Abstract] [Full Text] [Related]
48. Trained innate immunity, COVID-19 therapeutic dilemma, and fake science.
Belizário JE
Clinics (Sao Paulo); 2020; 75():e2124. PubMed ID: 32667492
[No Abstract] [Full Text] [Related]
49. SARS-CoV-2 (Covid-19): Interferon-epsilon may be responsible of decreased mortality in females.
Afsar CU; Afsar S
J Reprod Immunol; 2020 Sep; 141():103154. PubMed ID: 32521376
[No Abstract] [Full Text] [Related]
50. [Not Available].
Fumeaux T
Rev Med Suisse; 2020 Nov; 16(714):2190. PubMed ID: 33174705
[No Abstract] [Full Text] [Related]
51. Who Needs a Corona?
Winthrop KL
Arthritis Rheumatol; 2020 Jun; 72(6):874-876. PubMed ID: 32181583
[No Abstract] [Full Text] [Related]
52. Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection.
Netea MG; Giamarellos-Bourboulis EJ; Domínguez-Andrés J; Curtis N; van Crevel R; van de Veerdonk FL; Bonten M
Cell; 2020 May; 181(5):969-977. PubMed ID: 32437659
[TBL] [Abstract][Full Text] [Related]
53. What Would Jenner and Pasteur Have Done About COVID-19 Coronavirus? The Urges of a Vaccinologist.
Palatnik-de-Sousa CB
Front Immunol; 2020; 11():2173. PubMed ID: 32983183
[No Abstract] [Full Text] [Related]
54. Protective effects of vaccinations and endemic infections on COVID-19: A hypothesis.
Meenakshisundaram R; Senthilkumaran S; Thirumalaikolundusubramanian P
Med Hypotheses; 2020 Oct; 143():109849. PubMed ID: 32480250
[No Abstract] [Full Text] [Related]
55. COVID-19 and Bacillus Calmette-Guérin: What is the Link?
Hegarty PK; Sfakianos JP; Giannarini G; DiNardo AR; Kamat AM
Eur Urol Oncol; 2020 Jun; 3(3):259-261. PubMed ID: 32327396
[TBL] [Abstract][Full Text] [Related]
56. Coronavirus in China.
Burki TK
Lancet Respir Med; 2020 Mar; 8(3):238. PubMed ID: 32027848
[No Abstract] [Full Text] [Related]
57. Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia.
De Biasi S; Lo Tartaro D; Meschiari M; Gibellini L; Bellinazzi C; Borella R; Fidanza L; Mattioli M; Paolini A; Gozzi L; Jaacoub D; Faltoni M; Volpi S; Milić J; Sita M; Sarti M; Pucillo C; Girardis M; Guaraldi G; Mussini C; Cossarizza A
Eur J Immunol; 2020 Sep; 50(9):1283-1294. PubMed ID: 32910469
[TBL] [Abstract][Full Text] [Related]
58. The effect of Bacillus Calmette-Guérin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic.
Yitbarek K; Abraham G; Girma T; Tilahun T; Woldie M
Vaccine; 2020 Sep; 38(41):6374-6380. PubMed ID: 32798142
[TBL] [Abstract][Full Text] [Related]
59. BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis.
Tomita Y; Sato R; Ikeda T; Sakagami T
Vaccine; 2020 Sep; 38(41):6352-6356. PubMed ID: 32863070
[TBL] [Abstract][Full Text] [Related]
60. Cellular immune responses to covid-19.
Sewell HF; Agius RM; Stewart M; Kendrick D
BMJ; 2020 Jul; 370():m3018. PubMed ID: 32737031
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
